Evaluation of 12-Lipoxygenase (12-LOX) and Plasminogen Activator Inhibitor 1 (PAI-1) as Prognostic Markers in Prostate Cancer

In carcinoma of prostate, a causative role of platelet 12-lipoxygenase (12-LOX) and plasminogen activator inhibitor 1 (PAI-1) for tumor progression has been firmly established in tumor and/or adjacent tissue. Our goal was to investigate if 12-LOX and/or PAI-1 in patient's plasma could be used t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gondek, Tomasz, Szajewski, Mariusz, Szefel, Jarosław, Aleksandrowicz-Wrona, Ewa, Skrzypczak-Jankun, Ewa, Jankun, Jerzy, Lysiak-Szydlowska, Wieslawa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982265/
https://www.ncbi.nlm.nih.gov/pubmed/24783193
http://dx.doi.org/10.1155/2014/102478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982265/
https://www.ncbi.nlm.nih.gov/pubmed/24783193
http://dx.doi.org/10.1155/2014/102478

Ejemplares similares